Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 86.27

+6.0%

Jan 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2962)	7/1/2010 9:31:38 AM
From: Jibacoa	Read Replies (1) of 3722

ARNA is going to open with an UG.<g> bigcharts.marketwatch.com It is up 14% in pre-market tradingafter announcing that Eisai will market lorcaserin for obesity and weight management in the U.S. Lorcaserin, which ARNA has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.<g> As mentioned, the ACTAY is $6.02 And ARNA can have a good % gain from present levels.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next